Viruses (Feb 2023)

Circulating Interleukin-8 Dynamics Parallels Disease Course and Is Linked to Clinical Outcomes in Severe COVID-19

  • Ranit D’Rozario,
  • Deblina Raychaudhuri,
  • Purbita Bandopadhyay,
  • Jafar Sarif,
  • Priyanka Mehta,
  • Chinky Shiu Chen Liu,
  • Bishnu Prasad Sinha,
  • Jayasree Roy,
  • Ritwik Bhaduri,
  • Monidipa Das,
  • Sanghamitra Bandyopadhyay,
  • Shekhar Ranjan Paul,
  • Shilpak Chatterjee,
  • Rajesh Pandey,
  • Yogiraj Ray,
  • Dipyaman Ganguly

DOI
https://doi.org/10.3390/v15020549
Journal volume & issue
Vol. 15, no. 2
p. 549

Abstract

Read online

Severe COVID-19 frequently features a systemic deluge of cytokines. Circulating cytokines that can stratify risks are useful for more effective triage and management. Here, we ran a machine-learning algorithm on a dataset of 36 plasma cytokines in a cohort of severe COVID-19 to identify cytokine/s useful for describing the dynamic clinical state in multiple regression analysis. We performed RNA-sequencing of circulating blood cells collected at different time-points. From a Bayesian Information Criterion analysis, a combination of interleukin-8 (IL-8), Eotaxin, and Interferon-γ (IFNγ) was found to be significantly linked to blood oxygenation over seven days. Individually testing the cytokines in receiver operator characteristics analyses identified IL-8 as a strong stratifier for clinical outcomes. Circulating IL-8 dynamics paralleled disease course. We also revealed key transitions in immune transcriptome in patients stratified for circulating IL-8 at three time-points. The study identifies plasma IL-8 as a key pathogenic cytokine linking systemic hyper-inflammation to the clinical outcomes in COVID-19.

Keywords